Docoh
Loading...

CPMV Mosaic ImmunoEngineering

Patriot Scientific Corp. is a intellectual property licensing company with several patents, which design and development of microprocessor chips design. Its technologies are used in computers, cameras, printers, automotive and industrial devices. The company was founded on June 10, 1987 and is headquartered in Carlsbad, CA.

Company profile

Ticker
CPMV, PTSC
Exchange
Website
CEO
Carlton Johnson
Employees
Incorporated
Location
Fiscal year end
Former names
PATRIOT SCIENTIFIC CORP
SEC CIK
IRS number
841070278

CPMV stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

5 May 21
2 Aug 21
31 Dec 21
Quarter (USD)
Mar 21 Nov 20 Aug 20 May 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
May 20 May 19 May 18 May 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 210K 210K 210K 210K 210K 210K
Cash burn (monthly) 67.51K 59.67K 268.15K 138.28K 56.79K 45.04K
Cash used (since last report) 275.89K 243.87K 1.1M 565.11K 232.09K 184.09K
Cash remaining -65.89K -33.87K -885.86K -355.11K -22.09K 25.91K
Runway (months of cash) -1.0 -0.6 -3.3 -2.6 -0.4 0.6

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
7 May 21 Gloria Felcyn Convertible Note [object Object] Other Aquire J Yes No 25000 - 25K -
7 May 21 Robert L Garnick Convertible Note [object Object] Other Aquire J No No 100000 - 100K -
29 Apr 21 Nicole Franziska Steinmetz RSU Common Stock Grant Aquire A No No 2.8 5,357 15K 5,357
29 Jan 21 Nicole Franziska Steinmetz Common Stock Conversion Aquire C Yes No 0 570,870 0 570,870
29 Jan 21 Nicole Franziska Steinmetz Common Stock Conversion Aquire C No No 0 1,641,252 0 1,641,252
29 Jan 21 Nicole Franziska Steinmetz Series A Convertible Voting Preferred Stock Common Stock Conversion Dispose C Yes No 0 56,000 0 0
29 Jan 21 Nicole Franziska Steinmetz Series A Convertible Voting Preferred Stock Common Stock Conversion Dispose C No No 0 161,000 0 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 1 0 NEW
Opened positions 1 0 NEW
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 4.01B 0 NEW
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Western Reserve University Case 4.01B $0 NEW
Largest transactions
Shares Bought/sold Change
Western Reserve University Case 4.01B +4.01B NEW

Financial report summary

?
Management Discussion
  • Selling, general and administrative expenses increased from $734,062 for the fiscal year ended May 31, 2019 to $996,019 for the fiscal year ended May 31, 2020. The current fiscal year increase in expenses was primarily due to higher compensation expense mostly associated with severance expense paid to Mr. Flowers, our former Chief Financial Officer. Mr. Flowers resigned on September 30, 2019 and agreed to severance compensation of $327,750, in lieu of any amounts owed under his amended and restated employment agreement, payable in seven equal monthly installments commencing October 30, 2019. In addition, during the current fiscal year, we had an increase in consulting fees, mostly associated with the evaluation of new business opportunities in collaboration with Artius Bioconsulting LLC. These current fiscal year increases in expenses were offset by lower board fees as our board member volunteered to cease taking board fees.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: altering, attack, bid, called, deferral, Dr, earliest, effector, EPO, examination, exceed, Fiering, float, freezing, goal, injected, innate, microenvironment, Nicole, OTCQB, plant, profile, promise, reduction, refrigeration, regularly, requalify, secondary, sector, shareholder, showing, Simplifying, sought, spouse, Steinmetz, Steve, strong, sum, superior, thereon, tier, titled, Trademark, unrecognized, unvested, vitro
Removed: affiliated, aforementioned, annually, annum, approximate, caption, classification, comparability, continuing, derecognition, description, determination, direct, disclosing, entity, environment, evidence, exercise, exist, February, Framework, Holocom, impairment, influence, investee, lease, leasing, modify, narrative, objectively, prospectively, realized, recording, recoverable, refundable, representation, request, requirement, retrospectively, taxable, temporary, transmitted, transparency, unpaid, unrealized, verified, weight